Genmab · 13 hours ago
Director, Global Strategic & Analytic Pricing
Genmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Director, Global Pricing Analytics, will establish and lead a new capability focused on global pricing analytics, driving the development of frameworks to support optimal value capture across Genmab’s oncology portfolio.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Develop and implement robust pricing analytics frameworks to support strategic pricing decisions, including scenario planning, analog analysis, and forecasting
Design scalable pricing analytics processes that support future growth and evolving business needs
Implement and manage enterprise platforms and tools to enable scalable, real-time pricing insights and analytics, ensuring seamless integration across functions
Lead pricing analytics to support critical pricing activities including international reference pricing, parallel trade and launch sequencing optimization
Develop and implement dashboards and reports to monitor pricing and access performance across the portfolio
Collaborate with IT, Market Access, Commercial, Finance, and Compliance teams to ensure seamless experience for end users and enable efficient data flow and decision-making
Stay abreast of rapid AI advancements and leverage emerging technologies to enhance pricing analytics capabilities
Partner with external vendors and consultants to support pricing analytics projects and ensure high-quality deliverables
Monitor and analyze global pricing trends, competitor pricing strategies, and pricing policy changes to anticipate market dynamics and inform pricing recommendations
Contribute to pricing governance processes and support pricing submissions and negotiations as needed
Partner with Global Market Access & Pricing, Business Development and Commercial teams to inform pricing strategies for licensing, partnerships, and asset evaluations, ensuring alignment with Genmab’s long-term value creation goals
Qualification
Required
Ph.D., Pharm D, MD, M.Sc., or MBA in a relevant field (Health Economics, Data Science, Public Health, or Health Policy)
8+ years of experience in global pricing, market access, or health economics within the pharmaceutical or biotech industry
Proven expertise in pricing analytics, including hands-on experience with pricing models, forecasting tools, and enterprise platforms
Strong experience in leading launch sequencing optimization and international reference pricing
Deep understanding of global pricing regulations, HTA processes, and payer dynamics across key markets (e.g., US, EU5, Japan)
Proven experience working cross-functionally with internal partners to deliver pricing analytics solutions
Strong knowledge of AI trends and their application in pricing analytics and healthcare decision-making
Experience supporting early development programs with pricing input
Experience contributing pricing insights to business development activities, including asset evaluations
Track record of building new capabilities or functions within a matrixed organization
Experience with managed entry agreements/ contracting
Experience with implementation and management of internal pricing database
Strong leadership, influence, and stakeholder management skills
Fluency in English; additional language skills are a plus
Excellent interpersonal skills, including communication (oral and written), presentation, teamwork, persuasion, and influence
Proven ability to lead through influence in a matrixed organization, driving alignment and action across cross-functional teams without direct reporting lines
Comfortable operating independently and driving initiatives without direct team oversight
Strong project management and execution skills, with the ability to prioritize in a fast-paced environment
High sense of quality, personal drive, and a positive attitude
Creative problem-solver with a willingness to tackle unfamiliar challenges
Committed to contributing to the overall success of Genmab and its mission
Benefits
401(k) Plan: 100% match on the first 6% of contributions
Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Recent News
2026-01-11
Pharma Letter
2026-01-09
2026-01-09
Company data provided by crunchbase